Estrategia antivacunas de Kennedy podría forzar el retiro de vacunas del mercado, advierten fabricantes

Durante una cena bajo palmeras en la terraza de Mar-a-Lago en diciembre, el presidente electo Donald Trump tranquilizó a los directores ejecutivos de las farmacéuticas Eli Lilly y Pfizer diciéndoles que el activista antivacunas Robert F. Kennedy Jr. no sería una elección radical para dirigir el Departamento de Salud y Servicios Humanos (HHS). “Creo que…

Read More

Senior CDC Officials Resign After Monarez’s Ouster, Citing Concerns Over Scientific Independence

Four senior officials with the Centers for Disease Control and Prevention announced their resignations in recent days, citing what they described as growing political interference in the agency’s scientific work, particularly regarding vaccines. Two of them — Debra Houry, the CDC’s chief science and medical officer, and Demetre Daskalakis, who led the National Center for…

Read More

Blue States That Sued Kept Most CDC Grants, While Red States Feel Brunt of Trump Clawbacks

The Trump administration’s cuts to Centers for Disease Control and Prevention funding for state and local health departments had vastly uneven effects depending on the political leanings of a state, according to a KFF Health News analysis. Democratic-led states and select blue-leaning cities fought back in court and saw money for public health efforts restored…

Read More

As Measles Exploded, Officials in Texas Looked to CDC Scientists. Under Trump, No One Answered.

As measles surged in Texas early this year, the Trump administration’s actions sowed fear and confusion among CDC scientists that kept them from performing the agency’s most critical function — emergency response — when it mattered most, an investigation from KFF Health News shows. The outbreak soon became the worst the United States has endured…

Read More

Optum Rx Invokes Open Meetings Law To Fight Kentucky Counties on Opioid Suits

UnitedHealth Group’s multibillion-dollar pharmacy benefit manager, Optum Rx, is suing five Kentucky counties in an attempt to force them out of national opioid litigation against the company. Pharmacy benefit managers, often called PBMs, act as middlemen that negotiate prescription drug prices between drug companies, insurance plans, and pharmacies. Some lawyers and advocates say PBMs helped…

Read More